nodes	percent_of_prediction	percent_of_DWPC	metapath
Haloperidol—ABCB1—Methylprednisolone—psoriatic arthritis	0.069	0.0904	CbGbCtD
Haloperidol—CYP1A1—Dexamethasone—psoriatic arthritis	0.0668	0.0875	CbGbCtD
Haloperidol—CYP3A7—Dexamethasone—psoriatic arthritis	0.0535	0.07	CbGbCtD
Haloperidol—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.0535	0.07	CbGbCtD
Haloperidol—CYP2C19—Prednisone—psoriatic arthritis	0.0518	0.0679	CbGbCtD
Haloperidol—ABCB1—Betamethasone—psoriatic arthritis	0.0449	0.0588	CbGbCtD
Haloperidol—ABCB1—Prednisolone—psoriatic arthritis	0.0443	0.058	CbGbCtD
Haloperidol—ABCB1—Prednisone—psoriatic arthritis	0.0418	0.0548	CbGbCtD
Haloperidol—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0414	0.0542	CbGbCtD
Haloperidol—CYP3A5—Dexamethasone—psoriatic arthritis	0.0401	0.0525	CbGbCtD
Haloperidol—CYP2C19—Dexamethasone—psoriatic arthritis	0.0324	0.0424	CbGbCtD
Haloperidol—CYP3A4—Triamcinolone—psoriatic arthritis	0.0314	0.0411	CbGbCtD
Haloperidol—CYP2C9—Dexamethasone—psoriatic arthritis	0.0269	0.0352	CbGbCtD
Haloperidol—CYP3A4—Betamethasone—psoriatic arthritis	0.0269	0.0352	CbGbCtD
Haloperidol—CYP3A4—Prednisolone—psoriatic arthritis	0.0265	0.0348	CbGbCtD
Haloperidol—ABCB1—Dexamethasone—psoriatic arthritis	0.0261	0.0342	CbGbCtD
Haloperidol—CYP3A4—Prednisone—psoriatic arthritis	0.0251	0.0328	CbGbCtD
Haloperidol—CYP2D6—Dexamethasone—psoriatic arthritis	0.0246	0.0322	CbGbCtD
Haloperidol—ABCB1—Methotrexate—psoriatic arthritis	0.021	0.0275	CbGbCtD
Haloperidol—CYP3A4—Dexamethasone—psoriatic arthritis	0.0156	0.0205	CbGbCtD
Haloperidol—Photosensitivity—Methotrexate—psoriatic arthritis	0.000751	0.00318	CcSEcCtD
Haloperidol—Cardiac arrest—Prednisone—psoriatic arthritis	0.00075	0.00317	CcSEcCtD
Haloperidol—Visual impairment—Prednisolone—psoriatic arthritis	0.000724	0.00306	CcSEcCtD
Haloperidol—Weight increased—Dexamethasone—psoriatic arthritis	0.000712	0.00301	CcSEcCtD
Haloperidol—Weight increased—Betamethasone—psoriatic arthritis	0.000712	0.00301	CcSEcCtD
Haloperidol—Weight decreased—Betamethasone—psoriatic arthritis	0.000708	0.003	CcSEcCtD
Haloperidol—Weight decreased—Dexamethasone—psoriatic arthritis	0.000708	0.003	CcSEcCtD
Haloperidol—Hyperglycaemia—Betamethasone—psoriatic arthritis	0.000706	0.00299	CcSEcCtD
Haloperidol—Hyperglycaemia—Dexamethasone—psoriatic arthritis	0.000706	0.00299	CcSEcCtD
Haloperidol—Dermatitis exfoliative—Methotrexate—psoriatic arthritis	0.000699	0.00296	CcSEcCtD
Haloperidol—Visual disturbance—Methotrexate—psoriatic arthritis	0.000696	0.00294	CcSEcCtD
Haloperidol—Hallucination—Methylprednisolone—psoriatic arthritis	0.000686	0.0029	CcSEcCtD
Haloperidol—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.000677	0.00287	CcSEcCtD
Haloperidol—Lethargy—Methotrexate—psoriatic arthritis	0.000673	0.00285	CcSEcCtD
Haloperidol—Sweating increased—Prednisone—psoriatic arthritis	0.000664	0.00281	CcSEcCtD
Haloperidol—Visual impairment—Methylprednisolone—psoriatic arthritis	0.000664	0.00281	CcSEcCtD
Haloperidol—Eye disorder—Methylprednisolone—psoriatic arthritis	0.000644	0.00273	CcSEcCtD
Haloperidol—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.00064	0.00271	CcSEcCtD
Haloperidol—Neutropenia—Prednisone—psoriatic arthritis	0.000638	0.0027	CcSEcCtD
Haloperidol—Erectile dysfunction—Prednisone—psoriatic arthritis	0.000628	0.00266	CcSEcCtD
Haloperidol—Angiopathy—Methylprednisolone—psoriatic arthritis	0.000625	0.00265	CcSEcCtD
Haloperidol—Hallucination—Betamethasone—psoriatic arthritis	0.000623	0.00264	CcSEcCtD
Haloperidol—Hallucination—Dexamethasone—psoriatic arthritis	0.000623	0.00264	CcSEcCtD
Haloperidol—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.000622	0.00263	CcSEcCtD
Haloperidol—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.000621	0.00263	CcSEcCtD
Haloperidol—Weight increased—Prednisone—psoriatic arthritis	0.00062	0.00263	CcSEcCtD
Haloperidol—Weight decreased—Prednisone—psoriatic arthritis	0.000617	0.00261	CcSEcCtD
Haloperidol—Vision blurred—Prednisolone—psoriatic arthritis	0.000616	0.00261	CcSEcCtD
Haloperidol—Hyperglycaemia—Prednisone—psoriatic arthritis	0.000615	0.0026	CcSEcCtD
Haloperidol—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.000609	0.00258	CcSEcCtD
Haloperidol—Depression—Prednisone—psoriatic arthritis	0.000606	0.00256	CcSEcCtD
Haloperidol—Visual impairment—Dexamethasone—psoriatic arthritis	0.000604	0.00256	CcSEcCtD
Haloperidol—Visual impairment—Betamethasone—psoriatic arthritis	0.000604	0.00256	CcSEcCtD
Haloperidol—Mental disorder—Methylprednisolone—psoriatic arthritis	0.000604	0.00255	CcSEcCtD
Haloperidol—Malnutrition—Methylprednisolone—psoriatic arthritis	0.0006	0.00254	CcSEcCtD
Haloperidol—Breast disorder—Methotrexate—psoriatic arthritis	0.000596	0.00252	CcSEcCtD
Haloperidol—Vertigo—Prednisolone—psoriatic arthritis	0.000587	0.00249	CcSEcCtD
Haloperidol—Eye disorder—Dexamethasone—psoriatic arthritis	0.000586	0.00248	CcSEcCtD
Haloperidol—Eye disorder—Betamethasone—psoriatic arthritis	0.000586	0.00248	CcSEcCtD
Haloperidol—Angiopathy—Betamethasone—psoriatic arthritis	0.000569	0.00241	CcSEcCtD
Haloperidol—Angiopathy—Dexamethasone—psoriatic arthritis	0.000569	0.00241	CcSEcCtD
Haloperidol—Convulsion—Prednisolone—psoriatic arthritis	0.000566	0.0024	CcSEcCtD
Haloperidol—Hypertension—Prednisolone—psoriatic arthritis	0.000564	0.00239	CcSEcCtD
Haloperidol—Alopecia—Betamethasone—psoriatic arthritis	0.000554	0.00234	CcSEcCtD
Haloperidol—Alopecia—Dexamethasone—psoriatic arthritis	0.000554	0.00234	CcSEcCtD
Haloperidol—Hallucination—Prednisone—psoriatic arthritis	0.000543	0.0023	CcSEcCtD
Haloperidol—Pancytopenia—Methotrexate—psoriatic arthritis	0.000541	0.00229	CcSEcCtD
Haloperidol—Vertigo—Triamcinolone—psoriatic arthritis	0.00054	0.00229	CcSEcCtD
Haloperidol—Vertigo—Methylprednisolone—psoriatic arthritis	0.000539	0.00228	CcSEcCtD
Haloperidol—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000536	0.00227	CcSEcCtD
Haloperidol—Oedema—Prednisolone—psoriatic arthritis	0.000534	0.00226	CcSEcCtD
Haloperidol—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000534	0.00226	CcSEcCtD
Haloperidol—Neutropenia—Methotrexate—psoriatic arthritis	0.000533	0.00225	CcSEcCtD
Haloperidol—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.000525	0.00222	CcSEcCtD
Haloperidol—Convulsion—Triamcinolone—psoriatic arthritis	0.000521	0.0022	CcSEcCtD
Haloperidol—Tachycardia—Prednisolone—psoriatic arthritis	0.000521	0.0022	CcSEcCtD
Haloperidol—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.00052	0.0022	CcSEcCtD
Haloperidol—Convulsion—Methylprednisolone—psoriatic arthritis	0.00052	0.0022	CcSEcCtD
Haloperidol—Hypertension—Triamcinolone—psoriatic arthritis	0.000519	0.0022	CcSEcCtD
Haloperidol—Hypertension—Methylprednisolone—psoriatic arthritis	0.000518	0.00219	CcSEcCtD
Haloperidol—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000516	0.00218	CcSEcCtD
Haloperidol—Eye disorder—Prednisone—psoriatic arthritis	0.00051	0.00216	CcSEcCtD
Haloperidol—Anxiety—Methylprednisolone—psoriatic arthritis	0.000509	0.00215	CcSEcCtD
Haloperidol—Drowsiness—Methotrexate—psoriatic arthritis	0.000508	0.00215	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000507	0.00215	CcSEcCtD
Haloperidol—Depression—Methotrexate—psoriatic arthritis	0.000507	0.00214	CcSEcCtD
Haloperidol—Dry mouth—Triamcinolone—psoriatic arthritis	0.000501	0.00212	CcSEcCtD
Haloperidol—Angiopathy—Prednisone—psoriatic arthritis	0.000495	0.0021	CcSEcCtD
Haloperidol—Confusional state—Methylprednisolone—psoriatic arthritis	0.000494	0.00209	CcSEcCtD
Haloperidol—Immune system disorder—Prednisone—psoriatic arthritis	0.000493	0.00209	CcSEcCtD
Haloperidol—Oedema—Triamcinolone—psoriatic arthritis	0.000491	0.00208	CcSEcCtD
Haloperidol—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000491	0.00208	CcSEcCtD
Haloperidol—Vertigo—Betamethasone—psoriatic arthritis	0.00049	0.00207	CcSEcCtD
Haloperidol—Vertigo—Dexamethasone—psoriatic arthritis	0.00049	0.00207	CcSEcCtD
Haloperidol—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00049	0.00207	CcSEcCtD
Haloperidol—Insomnia—Prednisolone—psoriatic arthritis	0.000483	0.00204	CcSEcCtD
Haloperidol—Alopecia—Prednisone—psoriatic arthritis	0.000482	0.00204	CcSEcCtD
Haloperidol—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00048	0.00203	CcSEcCtD
Haloperidol—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00048	0.00203	CcSEcCtD
Haloperidol—Tachycardia—Triamcinolone—psoriatic arthritis	0.000479	0.00203	CcSEcCtD
Haloperidol—Mental disorder—Prednisone—psoriatic arthritis	0.000478	0.00202	CcSEcCtD
Haloperidol—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000478	0.00202	CcSEcCtD
Haloperidol—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000476	0.00201	CcSEcCtD
Haloperidol—Malnutrition—Prednisone—psoriatic arthritis	0.000475	0.00201	CcSEcCtD
Haloperidol—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000474	0.00201	CcSEcCtD
Haloperidol—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000474	0.00201	CcSEcCtD
Haloperidol—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000473	0.002	CcSEcCtD
Haloperidol—Convulsion—Dexamethasone—psoriatic arthritis	0.000473	0.002	CcSEcCtD
Haloperidol—Convulsion—Betamethasone—psoriatic arthritis	0.000473	0.002	CcSEcCtD
Haloperidol—Hypertension—Dexamethasone—psoriatic arthritis	0.000471	0.00199	CcSEcCtD
Haloperidol—Hypertension—Betamethasone—psoriatic arthritis	0.000471	0.00199	CcSEcCtD
Haloperidol—Anxiety—Dexamethasone—psoriatic arthritis	0.000463	0.00196	CcSEcCtD
Haloperidol—Anxiety—Betamethasone—psoriatic arthritis	0.000463	0.00196	CcSEcCtD
Haloperidol—Hypotension—Methylprednisolone—psoriatic arthritis	0.000457	0.00194	CcSEcCtD
Haloperidol—Hepatitis—Methotrexate—psoriatic arthritis	0.000456	0.00193	CcSEcCtD
Haloperidol—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00045	0.00191	CcSEcCtD
Haloperidol—Vision blurred—Prednisone—psoriatic arthritis	0.000448	0.00189	CcSEcCtD
Haloperidol—Urethral disorder—Methotrexate—psoriatic arthritis	0.000447	0.00189	CcSEcCtD
Haloperidol—Oedema—Betamethasone—psoriatic arthritis	0.000445	0.00188	CcSEcCtD
Haloperidol—Oedema—Dexamethasone—psoriatic arthritis	0.000445	0.00188	CcSEcCtD
Haloperidol—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000445	0.00188	CcSEcCtD
Haloperidol—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000445	0.00188	CcSEcCtD
Haloperidol—Insomnia—Triamcinolone—psoriatic arthritis	0.000444	0.00188	CcSEcCtD
Haloperidol—Insomnia—Methylprednisolone—psoriatic arthritis	0.000443	0.00187	CcSEcCtD
Haloperidol—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00044	0.00186	CcSEcCtD
Haloperidol—Visual impairment—Methotrexate—psoriatic arthritis	0.00044	0.00186	CcSEcCtD
Haloperidol—Anaemia—Prednisone—psoriatic arthritis	0.000439	0.00186	CcSEcCtD
Haloperidol—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000437	0.00185	CcSEcCtD
Haloperidol—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000437	0.00185	CcSEcCtD
Haloperidol—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000437	0.00185	CcSEcCtD
Haloperidol—Agitation—Prednisone—psoriatic arthritis	0.000437	0.00185	CcSEcCtD
Haloperidol—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000436	0.00184	CcSEcCtD
Haloperidol—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000436	0.00184	CcSEcCtD
Haloperidol—Tachycardia—Betamethasone—psoriatic arthritis	0.000434	0.00184	CcSEcCtD
Haloperidol—Tachycardia—Dexamethasone—psoriatic arthritis	0.000434	0.00184	CcSEcCtD
Haloperidol—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000432	0.00183	CcSEcCtD
Haloperidol—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000431	0.00182	CcSEcCtD
Haloperidol—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00043	0.00182	CcSEcCtD
Haloperidol—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00043	0.00182	CcSEcCtD
Haloperidol—Vertigo—Prednisone—psoriatic arthritis	0.000427	0.00181	CcSEcCtD
Haloperidol—Eye disorder—Methotrexate—psoriatic arthritis	0.000426	0.0018	CcSEcCtD
Haloperidol—Anorexia—Dexamethasone—psoriatic arthritis	0.000424	0.0018	CcSEcCtD
Haloperidol—Anorexia—Betamethasone—psoriatic arthritis	0.000424	0.0018	CcSEcCtD
Haloperidol—Urticaria—Prednisolone—psoriatic arthritis	0.000424	0.00179	CcSEcCtD
Haloperidol—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000423	0.00179	CcSEcCtD
Haloperidol—Hypotension—Betamethasone—psoriatic arthritis	0.000416	0.00176	CcSEcCtD
Haloperidol—Hypotension—Dexamethasone—psoriatic arthritis	0.000416	0.00176	CcSEcCtD
Haloperidol—Angiopathy—Methotrexate—psoriatic arthritis	0.000414	0.00175	CcSEcCtD
Haloperidol—Immune system disorder—Methotrexate—psoriatic arthritis	0.000412	0.00174	CcSEcCtD
Haloperidol—Convulsion—Prednisone—psoriatic arthritis	0.000412	0.00174	CcSEcCtD
Haloperidol—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000411	0.00174	CcSEcCtD
Haloperidol—Hypertension—Prednisone—psoriatic arthritis	0.00041	0.00174	CcSEcCtD
Haloperidol—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000404	0.00171	CcSEcCtD
Haloperidol—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000403	0.00171	CcSEcCtD
Haloperidol—Anxiety—Prednisone—psoriatic arthritis	0.000403	0.00171	CcSEcCtD
Haloperidol—Alopecia—Methotrexate—psoriatic arthritis	0.000403	0.00171	CcSEcCtD
Haloperidol—Insomnia—Betamethasone—psoriatic arthritis	0.000403	0.0017	CcSEcCtD
Haloperidol—Insomnia—Dexamethasone—psoriatic arthritis	0.000403	0.0017	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000402	0.0017	CcSEcCtD
Haloperidol—Mental disorder—Methotrexate—psoriatic arthritis	0.0004	0.00169	CcSEcCtD
Haloperidol—Malnutrition—Methotrexate—psoriatic arthritis	0.000397	0.00168	CcSEcCtD
Haloperidol—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000393	0.00166	CcSEcCtD
Haloperidol—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000392	0.00166	CcSEcCtD
Haloperidol—Dyspepsia—Betamethasone—psoriatic arthritis	0.000392	0.00166	CcSEcCtD
Haloperidol—Urticaria—Triamcinolone—psoriatic arthritis	0.00039	0.00165	CcSEcCtD
Haloperidol—Urticaria—Methylprednisolone—psoriatic arthritis	0.000389	0.00165	CcSEcCtD
Haloperidol—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000388	0.00164	CcSEcCtD
Haloperidol—Oedema—Prednisone—psoriatic arthritis	0.000388	0.00164	CcSEcCtD
Haloperidol—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000388	0.00164	CcSEcCtD
Haloperidol—Decreased appetite—Betamethasone—psoriatic arthritis	0.000387	0.00164	CcSEcCtD
Haloperidol—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000387	0.00164	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000384	0.00163	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000384	0.00163	CcSEcCtD
Haloperidol—Nervous system disorder—Prednisone—psoriatic arthritis	0.00038	0.00161	CcSEcCtD
Haloperidol—Tachycardia—Prednisone—psoriatic arthritis	0.000378	0.0016	CcSEcCtD
Haloperidol—Skin disorder—Prednisone—psoriatic arthritis	0.000377	0.00159	CcSEcCtD
Haloperidol—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000375	0.00159	CcSEcCtD
Haloperidol—Vision blurred—Methotrexate—psoriatic arthritis	0.000374	0.00158	CcSEcCtD
Haloperidol—Anorexia—Prednisone—psoriatic arthritis	0.00037	0.00156	CcSEcCtD
Haloperidol—Anaemia—Methotrexate—psoriatic arthritis	0.000367	0.00155	CcSEcCtD
Haloperidol—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000367	0.00155	CcSEcCtD
Haloperidol—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000367	0.00155	CcSEcCtD
Haloperidol—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000361	0.00153	CcSEcCtD
Haloperidol—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000361	0.00153	CcSEcCtD
Haloperidol—Vertigo—Methotrexate—psoriatic arthritis	0.000357	0.00151	CcSEcCtD
Haloperidol—Leukopenia—Methotrexate—psoriatic arthritis	0.000355	0.0015	CcSEcCtD
Haloperidol—Urticaria—Dexamethasone—psoriatic arthritis	0.000354	0.0015	CcSEcCtD
Haloperidol—Urticaria—Betamethasone—psoriatic arthritis	0.000354	0.0015	CcSEcCtD
Haloperidol—Dizziness—Prednisolone—psoriatic arthritis	0.000353	0.00149	CcSEcCtD
Haloperidol—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000352	0.00149	CcSEcCtD
Haloperidol—Body temperature increased—Betamethasone—psoriatic arthritis	0.000352	0.00149	CcSEcCtD
Haloperidol—Insomnia—Prednisone—psoriatic arthritis	0.000351	0.00148	CcSEcCtD
Haloperidol—Pruritus—Triamcinolone—psoriatic arthritis	0.000347	0.00147	CcSEcCtD
Haloperidol—Pruritus—Methylprednisolone—psoriatic arthritis	0.000346	0.00147	CcSEcCtD
Haloperidol—Convulsion—Methotrexate—psoriatic arthritis	0.000344	0.00146	CcSEcCtD
Haloperidol—Dyspepsia—Prednisone—psoriatic arthritis	0.000341	0.00144	CcSEcCtD
Haloperidol—Decreased appetite—Prednisone—psoriatic arthritis	0.000337	0.00143	CcSEcCtD
Haloperidol—Rash—Prednisolone—psoriatic arthritis	0.000336	0.00142	CcSEcCtD
Haloperidol—Dermatitis—Prednisolone—psoriatic arthritis	0.000336	0.00142	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000336	0.00142	CcSEcCtD
Haloperidol—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000335	0.00142	CcSEcCtD
Haloperidol—Headache—Prednisolone—psoriatic arthritis	0.000334	0.00141	CcSEcCtD
Haloperidol—Constipation—Prednisone—psoriatic arthritis	0.000332	0.0014	CcSEcCtD
Haloperidol—Confusional state—Methotrexate—psoriatic arthritis	0.000327	0.00138	CcSEcCtD
Haloperidol—Dizziness—Triamcinolone—psoriatic arthritis	0.000324	0.00137	CcSEcCtD
Haloperidol—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000324	0.00137	CcSEcCtD
Haloperidol—Dizziness—Methylprednisolone—psoriatic arthritis	0.000324	0.00137	CcSEcCtD
Haloperidol—Feeling abnormal—Prednisone—psoriatic arthritis	0.000319	0.00135	CcSEcCtD
Haloperidol—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000318	0.00134	CcSEcCtD
Haloperidol—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000317	0.00134	CcSEcCtD
Haloperidol—Nausea—Prednisolone—psoriatic arthritis	0.000317	0.00134	CcSEcCtD
Haloperidol—Pruritus—Dexamethasone—psoriatic arthritis	0.000315	0.00133	CcSEcCtD
Haloperidol—Pruritus—Betamethasone—psoriatic arthritis	0.000315	0.00133	CcSEcCtD
Haloperidol—Skin disorder—Methotrexate—psoriatic arthritis	0.000315	0.00133	CcSEcCtD
Haloperidol—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000313	0.00133	CcSEcCtD
Haloperidol—Vomiting—Triamcinolone—psoriatic arthritis	0.000312	0.00132	CcSEcCtD
Haloperidol—Vomiting—Methylprednisolone—psoriatic arthritis	0.000311	0.00132	CcSEcCtD
Haloperidol—Rash—Triamcinolone—psoriatic arthritis	0.000309	0.00131	CcSEcCtD
Haloperidol—Dermatitis—Triamcinolone—psoriatic arthritis	0.000309	0.00131	CcSEcCtD
Haloperidol—Anorexia—Methotrexate—psoriatic arthritis	0.000309	0.00131	CcSEcCtD
Haloperidol—Rash—Methylprednisolone—psoriatic arthritis	0.000309	0.00131	CcSEcCtD
Haloperidol—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000308	0.0013	CcSEcCtD
Haloperidol—Urticaria—Prednisone—psoriatic arthritis	0.000308	0.0013	CcSEcCtD
Haloperidol—Headache—Triamcinolone—psoriatic arthritis	0.000307	0.0013	CcSEcCtD
Haloperidol—Headache—Methylprednisolone—psoriatic arthritis	0.000307	0.0013	CcSEcCtD
Haloperidol—Body temperature increased—Prednisone—psoriatic arthritis	0.000306	0.0013	CcSEcCtD
Haloperidol—Diarrhoea—Betamethasone—psoriatic arthritis	0.000305	0.00129	CcSEcCtD
Haloperidol—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000305	0.00129	CcSEcCtD
Haloperidol—Hypotension—Methotrexate—psoriatic arthritis	0.000303	0.00128	CcSEcCtD
Haloperidol—Dizziness—Betamethasone—psoriatic arthritis	0.000294	0.00125	CcSEcCtD
Haloperidol—Dizziness—Dexamethasone—psoriatic arthritis	0.000294	0.00125	CcSEcCtD
Haloperidol—Insomnia—Methotrexate—psoriatic arthritis	0.000293	0.00124	CcSEcCtD
Haloperidol—Nausea—Triamcinolone—psoriatic arthritis	0.000291	0.00123	CcSEcCtD
Haloperidol—Nausea—Methylprednisolone—psoriatic arthritis	0.000291	0.00123	CcSEcCtD
Haloperidol—Dyspnoea—Methotrexate—psoriatic arthritis	0.000289	0.00122	CcSEcCtD
Haloperidol—Somnolence—Methotrexate—psoriatic arthritis	0.000288	0.00122	CcSEcCtD
Haloperidol—Hypersensitivity—Prednisone—psoriatic arthritis	0.000286	0.00121	CcSEcCtD
Haloperidol—Dyspepsia—Methotrexate—psoriatic arthritis	0.000285	0.00121	CcSEcCtD
Haloperidol—Vomiting—Betamethasone—psoriatic arthritis	0.000283	0.0012	CcSEcCtD
Haloperidol—Vomiting—Dexamethasone—psoriatic arthritis	0.000283	0.0012	CcSEcCtD
Haloperidol—Decreased appetite—Methotrexate—psoriatic arthritis	0.000282	0.00119	CcSEcCtD
Haloperidol—Rash—Dexamethasone—psoriatic arthritis	0.000281	0.00119	CcSEcCtD
Haloperidol—Rash—Betamethasone—psoriatic arthritis	0.000281	0.00119	CcSEcCtD
Haloperidol—Dermatitis—Dexamethasone—psoriatic arthritis	0.00028	0.00119	CcSEcCtD
Haloperidol—Dermatitis—Betamethasone—psoriatic arthritis	0.00028	0.00119	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00028	0.00118	CcSEcCtD
Haloperidol—Headache—Dexamethasone—psoriatic arthritis	0.000279	0.00118	CcSEcCtD
Haloperidol—Headache—Betamethasone—psoriatic arthritis	0.000279	0.00118	CcSEcCtD
Haloperidol—Pruritus—Prednisone—psoriatic arthritis	0.000274	0.00116	CcSEcCtD
Haloperidol—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000267	0.00113	CcSEcCtD
Haloperidol—Diarrhoea—Prednisone—psoriatic arthritis	0.000265	0.00112	CcSEcCtD
Haloperidol—Nausea—Betamethasone—psoriatic arthritis	0.000264	0.00112	CcSEcCtD
Haloperidol—Nausea—Dexamethasone—psoriatic arthritis	0.000264	0.00112	CcSEcCtD
Haloperidol—Urticaria—Methotrexate—psoriatic arthritis	0.000257	0.00109	CcSEcCtD
Haloperidol—Dizziness—Prednisone—psoriatic arthritis	0.000256	0.00108	CcSEcCtD
Haloperidol—Body temperature increased—Methotrexate—psoriatic arthritis	0.000256	0.00108	CcSEcCtD
Haloperidol—Vomiting—Prednisone—psoriatic arthritis	0.000247	0.00104	CcSEcCtD
Haloperidol—Rash—Prednisone—psoriatic arthritis	0.000244	0.00103	CcSEcCtD
Haloperidol—Dermatitis—Prednisone—psoriatic arthritis	0.000244	0.00103	CcSEcCtD
Haloperidol—Headache—Prednisone—psoriatic arthritis	0.000243	0.00103	CcSEcCtD
Haloperidol—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000239	0.00101	CcSEcCtD
Haloperidol—Nausea—Prednisone—psoriatic arthritis	0.00023	0.000975	CcSEcCtD
Haloperidol—Pruritus—Methotrexate—psoriatic arthritis	0.000229	0.00097	CcSEcCtD
Haloperidol—Diarrhoea—Methotrexate—psoriatic arthritis	0.000222	0.000938	CcSEcCtD
Haloperidol—Dizziness—Methotrexate—psoriatic arthritis	0.000214	0.000907	CcSEcCtD
Haloperidol—Vomiting—Methotrexate—psoriatic arthritis	0.000206	0.000872	CcSEcCtD
Haloperidol—Rash—Methotrexate—psoriatic arthritis	0.000204	0.000865	CcSEcCtD
Haloperidol—Dermatitis—Methotrexate—psoriatic arthritis	0.000204	0.000864	CcSEcCtD
Haloperidol—Headache—Methotrexate—psoriatic arthritis	0.000203	0.000859	CcSEcCtD
Haloperidol—Nausea—Methotrexate—psoriatic arthritis	0.000192	0.000814	CcSEcCtD
